Clinical assays for the assessment of the human epidermal growth factor receptor-2 (HER2) status in breast cancer include immunohistochemistry (IHC) and in situ hybridization (ISH), both of which have limitations. | A novel detection methodology for HER2 protein quantitation in formalin-fixed paraffin embedded clinical samples using fluorescent nanoparticles An analytical and clinical validation study